1. Home
  2. WOK vs VANI Comparison

WOK vs VANI Comparison

Compare WOK & VANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOK
  • VANI
  • Stock Information
  • Founded
  • WOK 2002
  • VANI 1998
  • Country
  • WOK China
  • VANI United States
  • Employees
  • WOK N/A
  • VANI N/A
  • Industry
  • WOK
  • VANI Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • WOK
  • VANI Health Care
  • Exchange
  • WOK NYSE
  • VANI Nasdaq
  • Market Cap
  • WOK 70.3M
  • VANI 69.9M
  • IPO Year
  • WOK 2024
  • VANI 2014
  • Fundamental
  • Price
  • WOK $5.01
  • VANI $1.20
  • Analyst Decision
  • WOK
  • VANI Strong Buy
  • Analyst Count
  • WOK 0
  • VANI 1
  • Target Price
  • WOK N/A
  • VANI $3.00
  • AVG Volume (30 Days)
  • WOK 221.3K
  • VANI 134.7K
  • Earning Date
  • WOK 02-03-2025
  • VANI 11-13-2024
  • Dividend Yield
  • WOK N/A
  • VANI N/A
  • EPS Growth
  • WOK N/A
  • VANI N/A
  • EPS
  • WOK N/A
  • VANI N/A
  • Revenue
  • WOK $9,863,642.00
  • VANI N/A
  • Revenue This Year
  • WOK N/A
  • VANI N/A
  • Revenue Next Year
  • WOK N/A
  • VANI N/A
  • P/E Ratio
  • WOK N/A
  • VANI N/A
  • Revenue Growth
  • WOK N/A
  • VANI N/A
  • 52 Week Low
  • WOK $3.26
  • VANI $1.01
  • 52 Week High
  • WOK $8.45
  • VANI $7.80
  • Technical
  • Relative Strength Index (RSI)
  • WOK N/A
  • VANI 43.85
  • Support Level
  • WOK N/A
  • VANI $1.17
  • Resistance Level
  • WOK N/A
  • VANI $1.23
  • Average True Range (ATR)
  • WOK 0.00
  • VANI 0.05
  • MACD
  • WOK 0.00
  • VANI 0.00
  • Stochastic Oscillator
  • WOK 0.00
  • VANI 31.58

About WOK WORK MEDICAL TECHNOLOGY GROUP LTD

WORK Medical Technology Group Ltd is a manufacturer of medical devices, and it is committed to providing professional and reliable medical devices to the world.

About VANI Vivani Medical Inc. (DE)

Vivani Medical Inc is a preclinical-stage biopharmaceutical company. It develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division.

Share on Social Networks: